NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
68 hedge funds and large institutions have $53.1M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
54% less call options, than puts
Call options by funds: $69K | Put options by funds: $149K
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 16
Holders
68
Holding in Top 10
3
Calls
$69K
Puts
$149K
Top Buyers
| 1 | +$1.46M | |
| 2 | +$578K | |
| 3 | +$94.5K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$54K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$53.4K |
Top Sellers
| 1 | -$644K | |
| 2 | -$222K | |
| 3 | -$138K | |
| 4 |
VF
Virtu Financial
New York
|
-$138K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$134K |